Pregnancy, Childbirth and the Puerperium | Women's Health, Phase Pilot

Pharmacokinetics and Hepatic Safety of EGCG

Volunteers
Health Professionals

What is the purpose of this trial?

A trial to assess the pharmacokinetics and hepatic safety of EGCG in women with and without uterine fibroids.

Trial with
National Institutes of Health (NIH)
Ages
18 years - 40 years
Gender
Female only

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Michele Frank

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Heping Zhang, PhD
Susan Dwight Bliss Professor of Biostatistics, Professor in the Child Study Center and Professor of Statistics and Data Science, Professor of Obstetrics, Gynecology, and Reproductive Sciences; Affiliated Faculty, Yale Institute for Global Health

Last Updated
03/18/2024
Study HIC
#2000029129